 Serum aminoterminal propeptide type III procollagen psoriasis psoriatic arthritis relation fibrosis arthritis Levels serum aminoterminal propeptide type III procollagen patients psoriasis coexistent psoriatic arthritis biopsies treatment methotrexate cases retinoids Psoriasis patients fibrosis cirrhosis liver biopsy specimens mean aminoterminal propeptide type III procollagen patients fibrosis arthritis patients cirrhosis fibrosis arthritis serum aminoterminal propeptide type III procollagen contrast patients psoriatic arthritis aminoterminal propeptide type III procollagen absence detectable liver fibrosis number liver biopsies methotrexate-treated psoriasis patients arthritis minimum serum aminoterminal propeptide type III procollagen normal serum aminoterminal propeptide type III procollagen absence arthritis strong indicator liver fibrogenesis need biopsy possible methotrexate-induced toxicity patients psoriatic arthritis aminoterminal propeptide type III procollagen joint disease Patients psoriatic arthritis increased levels aminoterminal propeptide type III procollagen guidelines use methotrexate psoriasis